Charles Schwab Investment Management Inc. boosted its holdings in shares of Clarivate Plc (NYSE:CLVT – Free Report) by 0.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,604,449 shares of the company’s stock after purchasing an additional 38,355 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.65% of Clarivate worth $32,692,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the business. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Clarivate by 5.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 29,557 shares of the company’s stock worth $168,000 after purchasing an additional 1,580 shares in the last quarter. Arizona State Retirement System boosted its position in Clarivate by 2.5% during the second quarter. Arizona State Retirement System now owns 84,172 shares of the company’s stock worth $479,000 after purchasing an additional 2,064 shares in the last quarter. KBC Group NV lifted its position in shares of Clarivate by 33.2% in the third quarter. KBC Group NV now owns 10,225 shares of the company’s stock valued at $73,000 after acquiring an additional 2,549 shares in the last quarter. Integrated Investment Consultants LLC lifted its position in shares of Clarivate by 2.9% in the third quarter. Integrated Investment Consultants LLC now owns 96,656 shares of the company’s stock valued at $686,000 after acquiring an additional 2,696 shares in the last quarter. Finally, OneDigital Investment Advisors LLC lifted its position in shares of Clarivate by 2.3% in the third quarter. OneDigital Investment Advisors LLC now owns 126,773 shares of the company’s stock valued at $900,000 after acquiring an additional 2,865 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.
Insiders Place Their Bets
In other Clarivate news, Director Michael J. Angelakis bought 765,000 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was bought at an average price of $5.19 per share, with a total value of $3,970,350.00. Following the completion of the purchase, the director now directly owns 3,465,000 shares in the company, valued at $17,983,350. The trade was a 28.33 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Bar Veinstein sold 120,000 shares of the firm’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $7.00, for a total value of $840,000.00. Following the sale, the insider now directly owns 976,583 shares of the company’s stock, valued at approximately $6,836,081. This trade represents a 10.94 % decrease in their position. The disclosure for this sale can be found here. 23.14% of the stock is owned by insiders.
Clarivate Stock Performance
Clarivate (NYSE:CLVT – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, hitting analysts’ consensus estimates of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The firm had revenue of $622.20 million for the quarter, compared to the consensus estimate of $640.81 million. During the same quarter last year, the business posted $0.18 earnings per share. The firm’s revenue was down 3.9% compared to the same quarter last year. As a group, research analysts forecast that Clarivate Plc will post 0.63 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the company. William Blair downgraded Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. Royal Bank of Canada decreased their target price on Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research report on Thursday, November 7th. Finally, Barclays decreased their target price on Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Clarivate currently has an average rating of “Hold” and an average price target of $7.25.
Check Out Our Latest Stock Report on Clarivate
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Read More
- Five stocks we like better than Clarivate
- Where Do I Find 52-Week Highs and Lows?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Earnings Per Share Calculator: How to Calculate EPS
- Netflix Is On Track To Hit $1,000 By Christmas
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.